1. Home
  2. FBIO vs PYN Comparison

FBIO vs PYN Comparison

Compare FBIO & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • PYN
  • Stock Information
  • Founded
  • FBIO 2006
  • PYN 2002
  • Country
  • FBIO United States
  • PYN United States
  • Employees
  • FBIO N/A
  • PYN N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • PYN Investment Managers
  • Sector
  • FBIO Health Care
  • PYN Finance
  • Exchange
  • FBIO Nasdaq
  • PYN Nasdaq
  • Market Cap
  • FBIO 39.4M
  • PYN 33.5M
  • IPO Year
  • FBIO N/A
  • PYN N/A
  • Fundamental
  • Price
  • FBIO $1.62
  • PYN $5.91
  • Analyst Decision
  • FBIO Strong Buy
  • PYN
  • Analyst Count
  • FBIO 3
  • PYN 0
  • Target Price
  • FBIO $18.00
  • PYN N/A
  • AVG Volume (30 Days)
  • FBIO 277.9K
  • PYN 19.9K
  • Earning Date
  • FBIO 03-27-2025
  • PYN 01-01-0001
  • Dividend Yield
  • FBIO N/A
  • PYN 5.07%
  • EPS Growth
  • FBIO N/A
  • PYN N/A
  • EPS
  • FBIO N/A
  • PYN N/A
  • Revenue
  • FBIO $81,501,000.00
  • PYN N/A
  • Revenue This Year
  • FBIO N/A
  • PYN N/A
  • Revenue Next Year
  • FBIO $128.63
  • PYN N/A
  • P/E Ratio
  • FBIO N/A
  • PYN N/A
  • Revenue Growth
  • FBIO 31.51
  • PYN N/A
  • 52 Week Low
  • FBIO $1.36
  • PYN $4.84
  • 52 Week High
  • FBIO $2.89
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 33.40
  • PYN 65.73
  • Support Level
  • FBIO $1.65
  • PYN $5.79
  • Resistance Level
  • FBIO $1.85
  • PYN $5.89
  • Average True Range (ATR)
  • FBIO 0.10
  • PYN 0.05
  • MACD
  • FBIO -0.01
  • PYN 0.01
  • Stochastic Oscillator
  • FBIO 7.32
  • PYN 100.00

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: